B. P. Hodkinson Et Al. , "Biomarkers of response to ibrutinib plus nivolumab in relapsed diffuse large B-cell lymphoma, follicular lymphoma, or Richter's transformation," TRANSLATIONAL ONCOLOGY , vol.14, no.1, 2021
Hodkinson, B. P. Et Al. 2021. Biomarkers of response to ibrutinib plus nivolumab in relapsed diffuse large B-cell lymphoma, follicular lymphoma, or Richter's transformation. TRANSLATIONAL ONCOLOGY , vol.14, no.1 .
Hodkinson, B. P., Schaffer, M., Brody, J. D., Jurczak, W., Carpio, C., Ben-Yehuda, D., ... Avivi, I.(2021). Biomarkers of response to ibrutinib plus nivolumab in relapsed diffuse large B-cell lymphoma, follicular lymphoma, or Richter's transformation. TRANSLATIONAL ONCOLOGY , vol.14, no.1.
Hodkinson, Brendan Et Al. "Biomarkers of response to ibrutinib plus nivolumab in relapsed diffuse large B-cell lymphoma, follicular lymphoma, or Richter's transformation," TRANSLATIONAL ONCOLOGY , vol.14, no.1, 2021
Hodkinson, Brendan P. Et Al. "Biomarkers of response to ibrutinib plus nivolumab in relapsed diffuse large B-cell lymphoma, follicular lymphoma, or Richter's transformation." TRANSLATIONAL ONCOLOGY , vol.14, no.1, 2021
Hodkinson, B. P. Et Al. (2021) . "Biomarkers of response to ibrutinib plus nivolumab in relapsed diffuse large B-cell lymphoma, follicular lymphoma, or Richter's transformation." TRANSLATIONAL ONCOLOGY , vol.14, no.1.
@article{article, author={Brendan P. Hodkinson Et Al. }, title={Biomarkers of response to ibrutinib plus nivolumab in relapsed diffuse large B-cell lymphoma, follicular lymphoma, or Richter's transformation}, journal={TRANSLATIONAL ONCOLOGY}, year=2021}